Tesamorelin FAQ: Your Questions Answered
The questions below are the ones that come up specifically about Tesamorelin, rather than general peptide questions that apply to everything.
In plain English
Frequent questions: what the cap actually does, how it differs from CJC-1295, why it dissolves so slowly, and what a missing-cap impurity means.
What Tesamorelin actually is
Tesamorelin keeps the body's own growth hormone-releasing signal completely intact — all forty-four amino acids — and adds one small chemical cap to the end. That cap exists for a single reason: an enzyme would otherwise destroy the natural molecule within minutes, and the cap blocks it from reaching its cutting point.
Supplied for laboratory research use only — not for human or animal use.
Third-party tested by HPLC and LC-MS, ≥99% purity, with a Certificate of Analysis on every order. Ships across Canada.
Technical detail below
Tesamorelin — common questions
What does the trans-3-hexenoic acid group do?
It blocks dipeptidyl peptidase-4 cleavage at the N-terminus. Native GHRH is degraded by DPP-4 within minutes; capping the N-terminus with the hexenoyl group removes that vulnerability while leaving receptor activity intact. It is a small structural change with a decisive stability consequence.
How does tesamorelin differ from CJC-1295?
Chain length and strategy. Tesamorelin is the full 44-residue GHRH sequence with an N-terminal cap. CJC-1295 is a truncated GHRH(1-29) fragment carrying internal amino-acid substitutions to resist degradation. Both address the same problem — GHRH's fragility — by different routes.
Why does tesamorelin dissolve more slowly than short peptides?
Chain length and the added hydrophobic acyl group. A 44-residue peptide has far more conformational complexity than a 7-residue one, and the lyophilized cake takes longer to hydrate. Slow dissolution here is expected behaviour, not a sign of a bad vial — the mistake would be to shake it.
What is a des-acyl impurity and why does it matter?
It is tesamorelin missing its N-terminal hexenoyl group — chemically, that is just unmodified GHRH. It would appear 96 Da lighter on the mass spectrum. It matters because the modification is the molecule's entire reason for existing, so des-acyl content is a more meaningful defect than a generic purity shortfall.
What Tesamorelin is studied for
Full-length GHRH activity with DPP-4 resistance conferred by the N-terminal modification.
The most distinctive endpoint in its research literature.
Studied for effects on endogenous GH secretion patterns rather than direct GH substitution.
Investigated alongside body-composition endpoints in metabolic research.
Summarizes published preclinical literature. Provided for research reference only; not a claim of efficacy or a description of human use.
More Tesamorelin reference
Lyophilized and reconstituted storage conditions, plus the practical working window.
Diluent selection, dissolution behaviour, and the calculator preset for this compound.
Which solvents work, why, and what abnormal dissolution behaviour indicates.
The specific chemical routes by which this molecule breaks down, and how to limit each.
Which assays are informative for this molecule, and what to actually check on its COA.
Compound-specific bench practices, and the errors most often made with this molecule.
What to inspect on arrival, and which conditions actually warrant rejecting a vial.
FAQ reference for other compounds
Tesamorelin is supplied strictly as a research chemical for in-vitro laboratory and research use only. It is not intended for human or animal consumption, diagnostic, or therapeutic use. This page is educational laboratory-handling reference information — not medical advice, not usage guidance, and not a protocol.